| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/07/1999 | EP0906428A1 Use of interleukin-10 to produce a population of suppressor cells |
| 04/07/1999 | EP0906427A1 Characterization of transfer factors and methods of use |
| 04/07/1999 | EP0906426A1 Antibodies to the ed-b domain of fibronectin, their construction and uses |
| 04/07/1999 | EP0906425A2 Vasoactive amine binding molecules |
| 04/07/1999 | EP0906424A2 Mammalian mixed lymphocyte receptors, chemokine receptors mmlr-ccr] |
| 04/07/1999 | EP0906423A1 Metastasis-associated antigen and antibodies thereto |
| 04/07/1999 | EP0906422A1 Human cell death-associated protein |
| 04/07/1999 | EP0906421A1 Enhanced efficacy of liposomal antisense delivery |
| 04/07/1999 | EP0906420A1 Programmed sequential mutagenesis |
| 04/07/1999 | EP0906419A2 Peptide ligands of the urokinase receptor |
| 04/07/1999 | EP0906418A1 Methods and compositions for cellular and metabolic engineering |
| 04/07/1999 | EP0906413A2 Dna encoding alpha-(1,4)-glucan acetyl-transferase |
| 04/07/1999 | EP0906337A2 AN ANTIGENIC EPITOPE OF THE u A /u DETERMINANT OF HEPATITIS B SURFACE ANTIGEN AND USES THEREOF |
| 04/07/1999 | EP0906330A1 STREPTOCOCCUS PNEUMONIAE ISOLEUCYL tRNA SYNTHETASE |
| 04/07/1999 | EP0906329A2 2'-substituted nucleosides and oligonucleotide derivatives |
| 04/07/1999 | EP0906328A1 Methods and compounds for curing diseases caused by mutations |
| 04/07/1999 | EP0906123A1 OLIGONUCLEOTIDES TARGETED TO ANGIOTENSINOGEN mRNA |
| 04/07/1999 | EP0906119A1 Method of treatment |
| 04/07/1999 | EP0906110A1 Dna vaccine formulations |
| 04/07/1999 | EP0906019A1 LIVE ATTENUATED VACCINES BASED ON cp45 HPIV-3 STRAIN AND METHOD TO ENSURE ATTENUATION IN SUCH VACCINES |
| 04/07/1999 | EP0792458A4 Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-beta peptide (x- 41) and tau |
| 04/07/1999 | EP0763112B1 Process for preparing doxorubicin |
| 04/07/1999 | EP0754227A4 Chimeric complement inhibitor proteins |
| 04/07/1999 | EP0752884A4 Method of treating auto-immune diseases using type one interferons |
| 04/07/1999 | EP0689447B1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 04/07/1999 | EP0672182A4 Genomic mismatch scanning. |
| 04/07/1999 | EP0671471B1 Process for producing foreign protein |
| 04/07/1999 | EP0654095A4 Electrophoresis of nucleic acid fragments. |
| 04/07/1999 | EP0642579B1 Improved methods for the preparation of endotoxin-binding proteins |
| 04/07/1999 | EP0625198B1 Expression of osteogenic factor op-1 in cells of spodoptera frugiperda infected with recombinant baculovirus |
| 04/07/1999 | EP0605586B1 Process for controlling lepidopteran pests |
| 04/07/1999 | EP0600868B1 Recombinantly produced lipases for therapeutical treatment |
| 04/07/1999 | EP0497784B1 Quantitation of nucleic acids using the polymerase chain reaction |
| 04/07/1999 | CN1213407A Compositions and method for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 04/07/1999 | CN1213406A Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylasse deficient cells |
| 04/07/1999 | CN1213405A Method for induction of genetic parthenocarpy in plants |
| 04/07/1999 | CN1213404A Genetic transformation of trees |
| 04/07/1999 | CN1213403A Polypeptides having mutanase activity and nucleic acids encoding same |
| 04/07/1999 | CN1213402A Recombinant expression of S-layer proteins |
| 04/07/1999 | CN1213401A Exodus chemokine materials and method |
| 04/07/1999 | CN1213380A Peptide immunogens for vaccination against and treatment of allergy |
| 04/07/1999 | CN1213312A Anticogulant agent useful in treatment of thrombosis |
| 04/07/1999 | CN1213004A Recombination leukocyte mesonium-2 adenovirus carrier and producing method |
| 04/07/1999 | CN1213003A 247 position single-mutant enzyme and 138, 247 position double-mutant enzyme of glucose isomerase and configuration method thereof |
| 04/07/1999 | CN1212967A Parathormone related protein human source antibody and its preparation method |
| 04/07/1999 | CN1212890A Compositions useful for transferring therapeutically active substances into target cell, and their use in gene therapy |
| 04/07/1999 | CA2249715A1 Abc transporter |
| 04/06/1999 | US5892071 Cationic transport reagents |
| 04/06/1999 | US5892070 Transgenic non-human mammals producing oligosaccharides and glycoconjugates |
| 04/06/1999 | US5892024 Bifunctional nucleosides, oligomers thereof, and methods of making and using the same |
| 04/06/1999 | US5892023 Synthetic nucleotide sequences for treatment of allergies by suppression of gene expression of immunoglobulin e receptors in effector cells |
| 04/06/1999 | US5892020 Multivalent single chain antibodies |
| 04/06/1999 | US5892019 Production of a single-gene-encoded immunoglobulin |
| 04/06/1999 | US5892018 Voltage independent, amiloride sensitive, sodium and lithium current, indiscriminant transport protein from human central nervous system; for diagnosis, gene therapy, and treatment of nervous system disorders |
| 04/06/1999 | US5892015 Human rhombotin-like protein |
| 04/06/1999 | US5892014 DNA encoding a protease-activated receptor 3 |
| 04/06/1999 | US5892012 Rab Proteins |
| 04/06/1999 | US5892009 DNA and encoded protein which regulates cold and dehydration regulated genes |
| 04/06/1999 | US5892004 Method for preparing PACAP receptor protein |
| 04/06/1999 | US5892003 Ciliary neurotrophic factor receptor antibodies |
| 04/06/1999 | US5892001 Epithelium-derived T-cell factor antibodies |
| 04/06/1999 | US5892000 From hybridomas 2g6 and b14; for immunoassay test kit used in diagnosis of athlerosclerosis and diabetes |
| 04/06/1999 | US5891998 Interleukin-6 receptor agonists |
| 04/06/1999 | US5891997 Receptor for oncostatin M |
| 04/06/1999 | US5891996 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use |
| 04/06/1999 | US5891994 Peptides and polypeptides which induce antibodies against hiv-1 tat proteins; for vaccines; diagnosis |
| 04/06/1999 | US5891991 Aplp1 and aplp2 are candidate genes for late onset familial alzheimer's disease. |
| 04/06/1999 | US5891859 Method for regulating cold and dehydration regulatory genes in a plant |
| 04/06/1999 | US5891858 Transforming growth factor alpha, treating prostate cancer |
| 04/06/1999 | US5891840 Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis |
| 04/06/1999 | US5891726 Cereal grains |
| 04/06/1999 | US5891725 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them |
| 04/06/1999 | US5891724 Transfecting cell with hybrid nucleic acid |
| 04/06/1999 | US5891718 Positive feedback antibiotic controlled eukaryotic expression vectors with single transcription unit of first cistron coding for gene product, second cistron coding for antibiotic controlled activator; gene therapy and gene immunization |
| 04/06/1999 | US5891716 An isolated nucleic acid comprising a nucleotide sequence encoding a peptide having at least one epitope recognized by a t cell receptor specific for allergen canis familiaris i or ii; medical diagnosis; antiallergens |
| 04/06/1999 | US5891714 Liposome-antisense oligonucleotide aggregate |
| 04/06/1999 | US5891710 Hybrid plasmid with a dna fragment that contains a genetic sequence that codes for betaine utilization and a mutation in the chromosomal gene coding for the betaine utilization. |
| 04/06/1999 | US5891706 Hybridoma cell line; therapy and diagnosis of autoimmune skin disorders, antitumor agents |
| 04/06/1999 | US5891704 Method to produce high levels of methioninase |
| 04/06/1999 | US5891703 Mutated penicillin G acylase genes |
| 04/06/1999 | US5891701 Nucleic acids encoding a polypeptide having protease activity |
| 04/06/1999 | US5891700 Receptor-type phosphotyrosine phosphatase-γ |
| 04/06/1999 | US5891699 Mutant hydrolase enzyme that demonstrates significantly improved activity and increase heat resistance; immunoenzymic assays and diagnostic kits |
| 04/06/1999 | US5891698 Oligosaccharides and glycoproteins produced in milk of transgenic non-human mammals |
| 04/06/1999 | US5891695 Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use |
| 04/06/1999 | US5891694 Method for recovering nucleic acid and device for the same purpose |
| 04/06/1999 | US5891693 The vectors comprise an active glutamine synthetase (gs) gene as well as a heterologous gene of interest to be expressed. |
| 04/06/1999 | US5891692 Method for increasing the viability and transformation ability of bacteria during or after storage at low temperatures |
| 04/06/1999 | US5891691 Method of producing a cell carrying an excess of mammalian centromeres and the cell line carrying an excess of mammalian centromeres |
| 04/06/1999 | US5891690 A process which reduces the presence of replication competent virus; for large scale production of infectious e1-deleted virions; for gene therapy of cystic fibrosis, duchenne muscular dystrophy; anticarcinogenic |
| 04/06/1999 | US5891689 Heme-bearing microparticles for targeted delivery of drugs |
| 04/06/1999 | US5891688 Regulatory protein having single amino acid substitutions creating an active protein not requiring normal phosphorylation; fungicides |
| 04/06/1999 | US5891687 Positive selection vector based on the caps gene, pCAPs vector and its use |
| 04/06/1999 | US5891686 Method of production of poly-β-hydroxyalkanoate copolymers |
| 04/06/1999 | US5891684 Base-modified enzymatic nucleic acid |
| 04/06/1999 | US5891683 Having enzymatic activity to cleave a target rna molecule, wherein said enzymatic nucleic acid molecule comprises an abasic moiety in a single-stranded region of said enzymatic nucleic acid molecule. |
| 04/06/1999 | US5891681 Modified promoter for RNA polymerase, its preparation and its applications |
| 04/06/1999 | US5891680 Dna molecule encoding an active il-12 fusion protein with at least two polypeptide monomers linked by heterologous polypeptide linker; stimulates ifn-alpha production, enhances antitumor immunity and cell mediated immunity |
| 04/06/1999 | US5891679 TNF-alpha muteins and a process for preparing them |
| 04/06/1999 | US5891678 Isolated polynucleotide encoding bacterial enzyme involved in mediating protein secretion; treatment of invasive infections and toxigenic diseases; antibiotic screening and development |